TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
Holders of 5% or more of TXMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TherapeuticsMD, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Clearline Capital LP | 13G | 5.50%635.2K shares | New | Feb 12, 20251 filing | Feb 12, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on TherapeuticsMD, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 20254:25 PM ET | Clearline Capital LPand 2 others | 13G | 5.50%635.2K shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell TherapeuticsMD, Inc. shares.
No Form 144 notices for TherapeuticsMD, Inc. are on file.